NCT06168773View on ClinicalTrials.gov

Combination of Haloperidol and Magnesium for Delirium Prevention in Critically Ill Elderly

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

October 24, 2023

Study Completion Date

November 4, 2023

Conditions

Delirium in Old Age

Interventions

DRUG

Haloperidol Injection

to evaluate the efficacy and safety of short-term intravenous combination of low-dose haloperidol and magnesium for delirium prevention in critically ill elderly patients after elective major surgery.

Trial Locations (1)

Unknown

AinShams university hospitals, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER